MBX Biosciences, Inc. MBX Net unrealized gains (losses) on securities still held
Net unrealized gains (losses) on securities still held at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s net unrealized gains (losses) on securities still held.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s net unrealized gains (losses) on securities still held?
- MBX Biosciences, Inc. (MBX) reported net unrealized gains (losses) on securities still held of -$892K in Q1 2026.
- How has MBX Biosciences, Inc.'s net unrealized gains (losses) on securities still held changed year-over-year?
- MBX Biosciences, Inc.'s net unrealized gains (losses) on securities still held decreased by 44500.0% year-over-year, from -$2K to -$892K.
- What does net unrealized gains (losses) on securities still held mean?
- This metric represents the change in the fair value of available-for-sale securities held by the company that have not yet been realized through a sale. It reflects market-driven fluctuations in the value of investment portfolios that are recognized in equity rather than the income statement. Monitoring this helps investors assess the impact of market volatility on the company's balance sheet and potential future liquidity.